The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review.
Chen Y, Zhao J, Wang Y, Ge L, Kwong JS, Lan J, Zhang R, Zhao H, Hu L, Wang J, Sun S, Tan S, Lin X, He R, Zheng W, Li X, Zhang J.
Chen Y, et al. Among authors: he r.
Front Pharmacol. 2025 Jan 15;15:1530999. doi: 10.3389/fphar.2024.1530999. eCollection 2024.
Front Pharmacol. 2025.
PMID: 39881866
Free PMC article.